Insights

DISCOVER

COMPANY

Survey

SURVEY

Consulting

COUNSULTING

Create New Account

Book discovery call

Nuclear Medicine Imaging Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21272

Download Sample Report

Published On

June 2021

Total pages

127 Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

INSTEAD OF PHYSICAL FORMS AND SHAPES, NUCLEAR MEDICINE IMAGING TAKES PHOTOS BASED ON THE CHEMISTRY OF THE HUMAN BODY. DUE TO THE RISING PREVALENCE OF TARGET ILLNESSES, THE TECHNOLOGY IS SEEING A SPIKE IN USAGE. SEVERAL HOSPITALS COMBINE NUCLEAR MEDICINE IMAGES WITH MRI (MAGNETIC RESONANCE IMAGING) OR CT (COMPUTED TOMOGRAPHY) TO CREATE DISTINCT VIEWS (IMAGE FUSION), ALLOWING DOCTORS TO ASSOCIATE AND INTERPRET DATA FROM TWO DIFFERENT TESTS ON A SINGLE IMAGE, RESULTING IN MORE ACCURATE INFORMATION AND PRECISE DIAGNOSES.

IN THE LAST DECADE, THERE HAS BEEN A MAJOR EVOLUTION OF HYBRID SYSTEMS DUE TO TECHNOLOGICAL BREAKTHROUGHS IN THE FIELD OF IMAGING. THE USE OF INTEGRATED PET MODALITIES IS A SIGNIFICANT ADVANCEMENT IN THIS AREA. THE PET/CT MODALITY HAS BEEN SO SUCCESSFUL IN TERMS OF INNOVATION THAT MAJOR IMAGING SYSTEM MANUFACTURERS NO LONGER OFFER SOLO PET SYSTEMS. FURTHERMORE, ONE OF THE KEY DRIVERS FOR THE MARKET IS THE GROWTH IN THE OCCURRENCE OF CANCER AND CARDIAC DISEASES. NUCLEAR MEDICINE HAS A LOT OF POTENTIAL FOR TREATING CANCER AND HEART DISEASE. THERE IS SUBSTANTIAL EVIDENCE THAT USING NUCLEAR IMAGING TECHNIQUES TO DIAGNOSE A TUMOUR HAS A GREATER INFLUENCE ON PATIENT MANAGEMENT IN TERMS OF TUMOUR SURVEILLANCE AND TREATMENT RESPONSE.

NUCLEAR IMAGING SYSTEMS ARE EXPENSIVE AND TAKE A LOT OF MONEY TO SET UP, WHICH DRIVES UP THE COST OF THE PROCEDURE FOR PATIENTS. THIS HAS AN IMPACT ON THE RATE OF ADOPTION OF NEW SYSTEMS, PARTICULARLY IN DEVELOPING NATIONS; AS A RESULT, MOST HEALTHCARE FACILITIES IN THESE NATIONS ARE UNABLE TO PURCHASE SUCH SYSTEMS. A PET SYSTEM COSTS BETWEEN USD 400,000 AND USD 600,000 IN RISING NATIONS LIKE BRAZIL, WHILE A SPECT SYSTEM COSTS BETWEEN USD 250,000 AND USD 400,000. THE MARKET'S GROWTH IS LIKELY TO BE HAMPERED BY THESE HIGH EXPENSES, WHICH WILL BE COMPOUNDED BY MAINTENANCE COSTS.

BASED ON PRODUCT, THE MARKET IS FRAGMENTED INTO SPECT IMAGING SYSTEMS, PET IMAGING SYSTEMS, AND PLANAR SCINTIGRAPHY IMAGING SYSTEMS. THE SPECT IMAGING SYSTEMS SEGMENT IS FURTHER CATEGORIZED INTO STANDALONE AND HYBRID IMAGING SYSTEMS. THE SPECT IMAGING SYSTEMS SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020. THE SPECT IMAGING SYSTEMS SEGMENT IS FURTHER CATEGORIZED INTO STANDALONE AND HYBRID IMAGING SYSTEMS THE MARKET IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027F OWING TO THE TECHNOLOGICAL ADVANCEMENT AND RISING ADOPTION OF THESE DEVICES ACROSS VARIOUS INDUSTRY.

BASED ON THE APPLICATION, THE MARKET IS FRAGMENTED INTO ONCOLOGY, CARDIOLOGY, NEUROLOGY, AND OTHERS. OWING TO THE RISING INCIDENCE AND PREVALENCE OF CANCER ACROSS THE GLOBE, INITIATIVES TAKEN BY PUBLIC AND PRIVATE ORGANIZATIONS TO CURB THE RISING CANCER PREVALENCE, AND THE DEVELOPMENT OF ADVANCED SYSTEMS AND RADIOTRACERS FOR ONCOLOGY. THE ONCOLOGY SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020 AND IS ANTICIPATED TO REACH USD XX MILLION BY THE YEAR 2027F, GROWING AT A CAGR OF XX% OVER THE FORECAST PERIOD (2021-2027).

BASED ON END-USERS, THE MARKET IS FRAGMENTED INTO HOSPITALS, IMAGING CENTERS, ACADEMIC & RESEARCH CENTERS, AND OTHERS. THE SPECT IMAGING SYSTEMS SEGMENT IS FURTHER CATEGORIZED INTO STANDALONE AND HYBRID IMAGING SYSTEMS. THE SPECT IMAGING SYSTEMS SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020. THE MARKET IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027F OWING TO THE TECHNOLOGICAL ADVANCEMENT AND RISING ADOPTION OF THESE DEVICES ACROSS VARIOUS INDUSTRY.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF THE NUCLEAR MEDICINE IMAGING MARKET, THE MARKET IS ANALYZED BASED ON ITS WORLDWIDE PENETRATION IN THE COUNTRIES SUCH AS NORTH AMERICA (UNITED STATES, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR MARKET FOR THE NUCLEAR MEDICINE IMAGING INDUSTRY AND GENERATED REVENUE OF USD XX MILLION IN 2020 OWING TO THE INCREASING INCIDENCE OF CHRONIC DISEASES, AND IMPROVEMENT OF HEALTHCARE SYSTEMS IN THE REGION. HOWEVER, THE ASIA PACIFIC REGION WOULD GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE SIEMENS HEALTHINEERS, GE HEALTHCARE, PHILIPS, DIGIRAD CORPORATION, MEDISO MEDICAL IMAGING SYSTEMS, POSITRON CORPORATION, CARDINAL HEALTH INC., BRACCO IMAGING SPA, HITACHI MEDICAL CORPORATION, CANON MEDICAL SYSTEMS CORPORATION, ETC. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

Scope of the Report

Products

Instead of physical forms and shapes, nuclear medicine imaging takes photos based on the chemistry of the human body.

Companies

SIEMENS HEALTHINEERS

GE HEALTHCARE

PHILIPS

DIGIRAD CORPORATION

MEDISO MEDICAL IMAGING SYSTEMS

POSITRON CORPORATION

CARDINAL HEALTH INC.

BRACCO IMAGING SPA

HITACHI MEDICAL CORPORATION

CANON MEDICAL SYSTEMS CORPORATION

1 MARKET INTRODUCTION

1.1 MARKET DEFINITIONS

1.2 OBJECTIVE OF THE STUDY

1.3 LIMITATION

1.4 STAKE HOLDERS

1.5 CURRENCY USED IN REPORT

1.6 SCOPE OF THE NUCLEAR MEDICINE IMAGING MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 RESEARCH METHODOLOGY FOR THE NUCLEAR MEDICINE IMAGING MARKET

2.1.1 MAIN OBJECTIVE OF THE NUCLEAR MEDICINE IMAGING MARKET

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPS UNDER NUCLEAR MEDICINE IMAGING SECTOR

6 NUCLEAR MEDICINE IMAGING AMID COVID-19

7 GLOBAL NUCLEAR MEDICINE IMAGING MARKET REVENUE (USD BN), 2019-2027F

8 MARKET INSIGHTS BY PRODUCT

8.1 SPECT IMAGING SYSTEMS

8.2 HYBRID SPECT IMAGING SYSTEMS

8.3 STANDALONE SPECT IMAGING SYSTEMS

8.4 PET IMAGING SYSTEMS

8.5 PLANAR SCINTIGRAPHY IMAGING SYSTEMSA

9 MARKET INSIGHTS BY APPLICATION

9.1 ONCOLOGY

9.2 CARDIOLOGY

9.3 NEUROLOGY

9.4 OTHERS

10 MARKET INSIGHTS BY END-USER

10.1 HOSPITALS

10.2 IMAGING CENTERS

10.3 ACADEMIC & RESEARCH CENTERS

10.4 OTHERS

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA NUCLEAR MEDICINE IMAGING MARKET

11.1.1 UNITED STATES

11.1.2 CANADA

11.1.3 REST OF NORTH AMERICA

11.2 EUROPE NUCLEAR MEDICINE IMAGING MARKET

11.2.1 GERMANY

11.2.2 FRANCE

11.2.3 UNITED KINGDOM

11.2.4 ITALY

11.2.5 SPAIN

11.2.6 REST OF EUROPE

11.3 ASIA-PACIFIC NUCLEAR MEDICINE IMAGING MARKET

11.3.1 CHINA

11.3.2 JAPAN

11.3.3 INDIA

11.3.4 AUSTRALIA

11.3.5 REST OF ASIA PACIFIC

11.4 REST OF WORLD NUCLEAR MEDICINE IMAGING MARKET

12 NUCLEAR MEDICINE IMAGING MARKET DYNAMICS

12.1 MARKET DRIVERS

12.2 MARKET CHALLENGES

12.3 IMPACT ANALYSIS

13 NUCLEAR MEDICINE IMAGING MARKET OPPORTUNITIES

14 NUCLEAR MEDICINE IMAGING MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1 DEMAND SIDE ANALYSIS

16.2 SUPPLY SIDE ANALYSIS

16.2.1 TOP PRODUCT LAUNCHES

16.2.2 TOP BUSINESS PARTNERSHIPS

16.2.3 TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

16.2.4 TOP MERGER AND ACQUISITIONS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1 PORTER'S FIVE FORCES ANALYSIS

18.1.1 BARGAINING POWER OF SUPPLIER

18.1.2 BARGAINING POWER OF BUYER

18.1.3 INDUSTRY RIVALRY

18.1.4 AVAILABILITY OF SUBSTITUTE

18.1.5 THREAT OF NEW ENTRANTS

18.2 COMPETITIVE LANDSCAPE

18.2.1 COMPANY SHARES, BY REVENUE

19 COMPANY PROFILED

19.1 SIEMENS HEALTHINEERS

19.2 GE HEALTHCARE

19.3 PHILIPS

19.4 DIGIRAD CORPORATION

19.5 MEDISO MEDICAL IMAGING SYSTEMS

19.6 POSITRON CORPORATION

19.7 CARDINAL HEALTH INC.

19.8 BRACCO IMAGING SPA

19.9 HITACHI MEDICAL CORPORATION

19.10 CANON MEDICAL SYSTEMS CORPORATION

20 DISCLAIMER

Research Methodology

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022